Previous Page  28 / 34 Next Page
Information
Show Menu
Previous Page 28 / 34 Next Page
Page Background

Page 65

Journal of Clinical Immunology and Allergy

ISSN: 2471-304X

16

th

EuroSciCon Conference on

Immunology

M a r c h 1 1 - 1 2 , 2 0 1 9

Am s t e r d a m , N e t h e r l a n d s

Immunology 2019

X

-linked Agammaglobulinemia (XLA) is a prototype primary antibody deficiency which is the most common form of primary

immunodeficiency diseases. Mutated BTK in these patients affect many immune cells, immunologic responses and molecular

interactions. TLRs, in a close interaction with BTK, reported being defected in different subcellular populations of PBMCs of XLA

patients. In this concern, we aimed to assess LPS and CpG-A stimulatory action on TLR4 and TLR9 by measuring the activation

of some TLR negative regulatory molecules’ transcription and cytokine production. Higher transcripts of SOCS1 and RNF216

were found in unstimulated PBMCs of patients. Despite this, interesting patterns of TLR-induced transcription were observed:

upregulation of IRAKM and SOCS1 in healthy subjects but downregulation in XLA, lack of RNF216 induction in healthy subjects

while downregulation in patients and similar TNFAIP3 downregulation in both XLA and healthy subjects. Further, a lower amount

of TNF-α was also produced by XLA patients PBMCs after LPS stimulation by disturbed cytokine production and dysregulated

transcription of selected downstream signalling molecules. Our results strengthen the potential TLRs defect pointing out TLR

involvement in the pathogenesis of different complications of XLA patients and also the scale of this defectiveness form TLRs

expression to downstream signalling and cytokine production.

rsanaei.rs@gmail.com

Disturbed gene expression of TLR negative

regulators in XLA patients

Roozbeh Sanaei

1

, Nima Rezaei

2

, Asghar Aghamohammadi

3

and Nader Tajik

1

1

Immunology Research Center (IRC), Institute of Immunology and Infectious Diseases, Iran

2

NIIMA, Universal Scientific Education and Research Network (USERN), Iran

3

Tehran University of Medical Sciences, Iran

J Clin Immunol Allergy 2019, Volume:5

DOI: 10.21767/2471-304X-C1-009